Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
Eli Lilly and Company
Verismo Therapeutics
GenomeFrontier Therapeutics TW Co., Ltd.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Pell Bio-Med Technology Co., Ltd.
ImmunityBio, Inc.
Nkarta, Inc.
Juno Therapeutics, a Subsidiary of Celgene
Athenex, Inc.
Atara Biotherapeutics
Gilead Sciences
Novartis
Morphotek
Seagen Inc.
Cellerant Therapeutics
SymBio Pharmaceuticals
Enzon Pharmaceuticals, Inc.
Daiichi Sankyo
Seagen Inc.
NKBio Co.Ltd.
Bristol-Myers Squibb
MedImmune LLC
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service